Genetics of β-Amyloid Precursor Protein in Alzheimer's Disease

TCW, Julia, Goate, Alison M.·2017·Cold Spring Harbor Perspectives in Medicine
DOI 10.1101/cshperspect.a024539

Cited by (242)

Items 101–200 of 242

  1. NLRP3 inflammasome and Alzheimer’s disease: bridging inflammation and neurodegeneration
    Rufaida Wasim, Sumaiya Azmi, Asad Ahmad, Akash Srivastava · 2026 · Inflammopharmacology
  2. Nanodelivery of oxiracetam enhances memory, functional recovery and induces neuroprotection following concussive head injury.
    Feng Niu, Aruna Sharma, Zhenguo Wang, Lian-Yuan Feng, D. Muresanu, S. Sahib, Z. Tian, J. Lafuente, A. Buzoianu, R. Castellani et al. · 2021 · Progress in Brain Research
  3. SPLICER: a highly efficient base editing toolbox that enables in vivo therapeutic exon skipping
    Angelo Miskalis, Shraddha Shirguppe, Jackson Winter, Gianna Elias, Devyani Swami, Ananthan Nambiar, Michelle Stilger, Wendy S. Woods, Nicholas C. Gosstola, Michael Gapinske et al. · 2024 · Nature Communications
  4. Unveiling the mTOR pathway modulation by SGLT2 inhibitors: a novel approach to Alzheimer’s disease in type 2 diabetes
    Prakash Ramakrishan, Jayaraman Rajangam, Shaheedha Shabudeen Mahinoor, Shradha Bisht, Sabareesh Mekala, Dinesh Kumar Upadhyay, Viswas Raja Solomon, Govindaraj Sabarees, Ranakishor Pelluri · 2025 · Metabolic Brain Disease
  5. Rapid Identification of 3,6′-Disinapoyl Sucrose Metabolites in Alzheimer’s Disease Model Mice Using UHPLC–Orbitrap Mass Spectrometry
    Jiaqi Yuan, Han Wang, Yunting Wang, Zijian Wang, Qing Huo, Xueling Dai, Jiayu Zhang, Yaxuan Sun · 2021 · Molecules
  6. Evaluation of Anti‐Alzheimer Activity of Synthetic Coumarins by Combination of in Vitro and in Silico Approaches
    İlkay Erdoğan Orhan, Fatma Sezer Şenol, Ramin Ekhteiari Salmas, Sule Irmak, Özden Özgün, Gurbet Çelik Turgut, Alaattin Şen, Ana‐Maria Zbancioc, Simon Vlad Luca, Adrianna Skiba et al. · 2022 · Chemistry & Biodiversity
  7. Clearing Amyloid-Beta by Astrocytes: The Role of Rho GTPases Signaling Pathways as Potential Therapeutic Targets
    Gyeongah Park, Zhen Jin, Hui Lu, Jianyang Du · 2024 · Brain Science
  8. Rodent models of Alzheimer's disease: Critical analysis of current hypotheses and pathways for future research
    Pasindu Hansana Singhaarachchi, Péter Antal, Frédéric Calon, Carsten Culmsee, Jean-Christophe Delpech, Martin Feldotto, Jorine Geertsema, Emmy E. Hoeksema, Anikó Kőrösi, Sophie Layé et al. · 2025 · Progress in Neurobiology
  9. Single‐cell landscape analysis reveals systematic senescence in mammalian Down syndrome
    Yao Chen, Yanyu Xiao, Yanye Zhang, Renying Wang, Feixia Wang, Huajing Gao, Yifeng Liu, Runju Zhang, Huiyu Sun, Ziming Zhou et al. · 2023 · Clinical and Translational Medicine
  10. The Other Side of Alzheimer’s Disease: Influence of Metabolic Disorder Features for Novel Diagnostic Biomarkers
    Chiara Argentati, Ilaria Tortorella, Martina Bazzucchi, Carla Emiliani, Francesco Morena, Sabata Martino · 2020 · Journal of Personalized Medicine
  11. Patient-derived iPSCs, a reliable in vitro model for the investigation of Alzheimer’s disease
    Ernest Amponsah Asiamah, Ruiyun Guo, Desheng Kong, Baofeng Feng, Jingjing He, Wei Zhang, Xin Liu, Xiaofeng Du, Zhenhuan Ma, Boxin Liu et al. · 2021 · Reviews in the Neurosciences
  12. Role of Neurexins in Alzheimer's Disease
    Almudena Medina-Samamé, Éva Paller, Mateo R. Bril, Ana Archvadze, Madalena B C Simões-Abade, Patricia Estañol Cayuela, Chloe LeMaoult · 2023 · Journal of Neuroscience
  13. Anthocyanidins Intake is Associated with Alzheimer’s Disease Risk in Americans over 60 Years of Age: Data from NHANES 2007-2008, 2009-2010, and 2017-2018
    Yan Chen, Jingyi Zhao, Chen Li, Yinhui Yao, Shang Yazhen · 2025 · Current Alzheimer Research
  14. Deep learning, network pharmacology and computational simulation reveal multi-target therapeutic mechanisms of Vitis vinifera (Grapes) compounds against Alzheimer’s disease
    Md. Mainuddin Hossain, Juthi Adhikari, Abu Zaffar Shibly · 2025 · In Silico Research in Biomedicine
  15. Alzheimer’s disease and clinical trials
    Deepraj Paul, Rohini Agrawal, Swati Singh · 2024 · Journal of Basic and Clinical Physiology and Pharmacology
  16. Heterologous expression of BACE1 and its interaction with Codonopsis pilosula polysaccharides and Lobetyolin
    Feitao Zhao, Lili Fan, Jumei Yang, Mingjun Yang, Chun Zhang, Fang Wang, Yonggang Wang · 2024 · International Journal of Biological Macromolecules
  17. A stilbenoid, rhapontigenin, isolated from the root of Rheum palmatum L. acts as a potent BACE1 inhibitor
    Jong Min Oh, Soo Hyun Kim, Bishnu Prasad Pandey, Woong‐Hee Shin, Hyun Ju Son, Yun Ju Kwon, Hoon Kim · 2025 · Fitoterapia
  18. Τhe Greek Variant in APP Gene: The Phenotypic Spectrum of APP Mutations
    Stefania Kalampokini, Despoina Georgouli, Eleni Patrikiou, Antonios Provatas, Varvara J Valotassiou, Panagiotis Georgoulias, Cleanthe Spanaki, Georgios M. Hadjigeorgiou, Georgia Xiromerisiou · 2021 · International Journal of Molecular Sciences
  19. Zebrafish Experimental Animal Models for AD: A Comprehensive Review
    Ruksar Sande, Angel Pavalu Godad, Gaurav Doshi · 2024 · Current Clinical Pharmacology
  20. The genetic landscape of early and late-onset Alzheimer’s disease: A review
    Paula Denisa Saragea · 2024 · Acta Marisiensis. Seria Medica
  21. HMGA1 deficiency: a pathogenic link between tau pathology and insulin resistance
    Maria Mirabelli, EUSEBIO D. CHIEFARI, Biagio Arcidiacono, Alessandro Salatino, Angelo Pascarella, Maurizio Morelli, Sara Carmela Credendino, Francesco S. Brunetti, Anna Di Vito, Adelaide Greco et al. · 2025 · EBioMedicine
  22. Exploring the Involvement of the Amyloid Precursor Protein A673T Mutation against Amyloid Pathology and Alzheimer’s Disease in Relation to Therapeutic Editing Tools
    Gabriela Dumitriţa Stanciu, Daniela Carmen Ababei, Răzvan-Nicolae Rusu, Veronica Bild, Bogdan-Ionel Tamba · 2022 · Pharmaceutics
  23. Inference for a Large Directed Acyclic Graph with Unspecified Interventions
    Chunlin Li, Xiaotong Shen, Wei Pan · 2021 · PubMed
  24. Upregulation of extracellular proteins in a mouse model of Alzheimer’s disease
    Sangkyu Kim, Jessica Fuselier, Anna Latoff, Justin Manges, S. Michal Jazwinski, Andrea Zsombok · 2023 · Scientific Reports
  25. Monoamine Oxidase Inhibitory Effects of Medicinal Plants in Management of Alzheimer's Disease
    Tuba Ege, Hayriye Deniz ŞELİMEN · 2021 · Journal of the Turkish Chemical Society Section A Chemistry
  26. Astrocytic and microglial cell functions in neuroinflammatory diseases and their animal models
    Kei Hashimoto, Mari Gotoh, Hiroko Ikeshima‐Kataoka · 2025 · Frontiers in Cellular Neuroscience
  27. A Novel Perspective on PCSK9 in Alzheimer’s Disease: A Focus on Amyloid Beta
    Huayu Zhang, Qian Feng Xu, Yimeng Zhao, Naiqi He, Zhong Ren, Qiong Xiang, Zhi‐Han Tang, Lushan Liu · 2024 · Current Medicinal Chemistry
  28. iPSC ‐derived human cortical organoids display profound alterations of cellular homeostasis following SARS ‐ CoV ‐2 infection and Spike protein exposure
    Gioia Cappelletti, Lorenzo Brambilla, Sergio Strizzi, Fiona Limanaqi, Valentina Melzi, Mafalda Rizzuti, Monica Nizzardo, Irma Saulle, Daria Trabattoni, Stefania Paola Corti et al. · 2025 · The FASEB Journal
  29. Implications of Mucin-Type O-Glycosylation in Alzheimer’s Disease
    Nancy Vela Navarro, Gustavo De Nadai Mundim, Mare Čudić · 2025 · Molecules
  30. Stem cell-based therapeutic strategies for down syndrome and Alzheimer’s disease
    Osama Hamadelseed, Thomas Skutella · 2025 · Stem Cell Research & Therapy
  31. Rare Amyloid Precursor Protein Point Mutations Recapitulate Worldwide Migration and Admixture in Healthy Individuals: Implications for the Study of Neurodegeneration
    Paolo Abondio, Francesco Bruno, Amalia Cecilia Bruni, Donata Luiselli · 2022 · International Journal of Molecular Sciences
  32. Incident Dementia After Spontaneous Intracerebral Hemorrhage
    Zhe-Ting Zhang, Mervyn Jun Rui Lim · 2024 · Journal of Alzheimer's Disease
  33. Leveraging omic features with F3UTER enables identification of unannotated 3’UTRs for synaptic genes
    Siddharth Sethi, David Zhang, Sebastian Guelfi, Zhongbo Chen, Sonia García-Ruiz, Emmanuel O. Olagbaju, Mina Ryten, Harpreet Kaur Saini, Juan Antonio Botía · 2022 · Nature Communications
  34. Discovery and Inference of a Causal Network with Hidden Confounding
    Li Chen, Chunlin Li, Xiaotong Shen, Wei Pan · 2023 · Journal of the American Statistical Association
  35. What Can We Learn About Alzheimer’s Disease from People with Down Syndrome?
    Lucía Maure‐Blesa, Íñigo Rodríguez‐Baz, María Carmona‐Iragui, Juan Fortea · 2024 · Current topics in behavioral neurosciences
  36. Evaluation of the Anti-Amyloid and Anti-Inflammatory Properties of a Novel Vanadium(IV)–Curcumin Complex in Lipopolysaccharides-Stimulated Primary Rat Neuron-Microglia Mixed Cultures
    Georgios Katsipis, Sophia N. Lavrentiadou, George D. Geromichalos, Maria P. Tsantarliotou, Eleftherios G. Halevas, G. Litsardakis, Αnastasia A. Pantazaki · 2024 · International Journal of Molecular Sciences
  37. Recent Advances and Future Directions in Alzheimer’s Disease Genetic Research
    Mikaela Stancheva, Draga I. Toncheva, Sena Karachanak-Yankova · 2025 · International Journal of Molecular Sciences
  38. The association between omega-3 supplementation and cognitive decline in older adults
    Zheng-Bin Liao, Zicheng Hu, Gui‐Hua Zeng, Jia Chen, Xinpeng Li, Y F Liu, Xiu‐Qing Yao, Ye‐Ran Wang · 2026 · The Journal of Prevention of Alzheimer s Disease
  39. OXIDATIVE STRESS IN ALZHEIMER’S DISEASE–EVALUATING THE AMYLOID BETA HYPOTHESIS
    SWETHA G., Anjali Raj, SANIYA TABASSUM, Douglas Chhakchhuak · 2021 · International Journal of Current Pharmaceutical Research
  40. Knockdown of BACE1 by a multistage brain-targeting polyion complex improved memory and learning behaviors in APP/PS1 transgenic mouse model
    Tingting Jia, Hongbo Wang, Wenya Chi, Wenbo Zhou, Lingyi Guo, Yu Dai, Kangqing Bian, Zhiguo Sun, Xueying Ding, Yuan Yu · 2023 · International Journal of Pharmaceutics
  41. Integrating chemical analysis with in vitro, in silico, and network pharmacology to discover potential functional compounds from Marrubium astracanicum subsp. macrodon
    Ömer Kaan Avşar, Sevgi Kasbolat, Güneş Ak, Nilofar Nilofar, Giovanni Caprioli, Agnese Santanatoglia, Ahmet Uysal, Abdullahi İbrahim Uba, Sathish Kumar M. Ponniya, Mehmet Yavuz Paksoy et al. · 2024 · Journal of Molecular Liquids
  42. Neuropathology of patients with preclinical or early clinical Alzheimer's disease with pathogenic PSEN1_p. L392V: Comparison of advanced siblings
    Yukiko Hata, Mio Nakase, Shojiro Ichimata, Kōji Yoshida, Naoki Nishida · 2024 · Alzheimer s & Dementia
  43. Functional analysis of juxta- and intra-membrane domains of murine APP by genome editing in Neuro2a cells
    Nanaka Kaneshiro, Ryosuke Imaoka, Masato Komai, Taku Kashiyama, Takashi Sakurai, Takashi Uehara, Nobumasa Takasugi · 2018 · Biochemical and Biophysical Research Communications
  44. Sex differences in sleep fragmentation in 5xFAD mice
    Kaitlyn Kim, Angel-Rose Villegas, Amanda Kelley, Edwin M. Labut, Tory M. Hagen, Kathy Ruth Magnusson, Heidi E. Kloefkorn · 2025 · Neuroscience
  45. SLC30A3 as a Zinc Transporter-Related Biomarker and Potential Therapeutic Target in Alzheimer’s Disease
    Ruyu Bai, Zhiyun Cheng, Yong Diao · 2025 · Genes
  46. Methods to study the effect of solution variables on the conformational dynamics of intrinsically disordered proteins
    Hakan Alıcı, Orkun Hasekioğlu, Vladimir Nikolaevich Uversky, Orkid Coskuner‐Weber · 2022 · Elsevier eBooks
  47. Effects of Angiotensin-I-Converting Enzyme (ACE) Mutations Associated with Alzheimer’s Disease on Blood ACE Phenotype
    Olga V. Kryukova, Igor O. Islanov, Elena V. Zaklyazminskaya, Dmitriy O. Korostin, Vera Belova, Valery V. Cheranev, Zhanna A. Repinskaia, Svetlana A. Tonevitskaya, Pavel A. Petukhov, Steven M. Dudek et al. · 2024 · Biomedicines
  48. Anti-inflammatory and antioxidant effects of fenugreek in preventing mice model of Alzheimer's disease
    Li Xiong, Qinxuan Li, Xuhui Zhou, Jiujia Xiao, Xingyu Yang, Hengxiang Xu, Chuan Guo · 2025 · Journal of Alzheimer s Disease Reports
  49. Generation and characterization of a human induced pluripotent stem cell line (XWHNi001-A) derived from an Alzheimer's disease patient with mutation in the APP gene
    Cuibai Wei, Xinliang Lu, Qi Zou, Shuting Gong, Yufei Chen, Jihui Lyu, Jianping Jia · 2022 · Stem Cell Research
  50. Insights into the promising prospect of pharmacological approaches targeting mitochondrial dysfunction in major human diseases: At a glance
    Md. Mominur Rahman, Md. Taslim Sarker, Sabbir Ahmed, Md.Nur Uddin, Md. Rezaul Islam, Md. Rezaul Islam, Shanto Das, Nobendu Mukherjee, Hassan A. Hemeg, Abdur Rauf et al. · 2023 · Process Biochemistry
  51. Neurogenetics: Precision Medicine-Based Approaches to Neurological Disorders with an Emphasis on Addressing Alzheimer’s Disease and Schizophrenia
    Nethra Srinivasan, Eshaan Mehra, Sriya Dommaraju, Ethan Kakavetsis · 2024 · Berkeley Pharma Tech Journal of Medicine
  52. Alzheimer’s Disease: An Outline of Therapeutic Interventions by different Approaches
    H Y Dyuthi, U. Rajashekhar · 2024 · Research Journal of Pharmacology and Pharmacodynamics
  53. Oligonucleotide therapeutics for neurodegenerative diseases
    Victor C. Li, Yunlong Huang · 2024 · NeuroImmune Pharmacology and Therapeutics
  54. Genetics of intracerebral hemorrhage
    Tamara N. Kimball, Reinier W. P. Tack, Anna Chen, Savvina Prapiadou, Jasper Rudolf Senff, Benjamin Yong‐Qiang Tan, Sanjula Singh, Susanne J. van Veluw, Steven Mark Greenberg, Jonathan M. Rosand et al. · 2025 · Journal of Cerebral Blood Flow & Metabolism
  55. Advancing Alzheimer's Therapy with Moringa oleifera: Bioactive Insights, Mechanistic Pathways, and Strategies for Efficacy and Standardization
    Nur Irlia Sofea Mohammad Zamani, Faidruz Azura Jam, Liew Jia Yi, Chua Wan Yi, T R Lakshmi And Rajendran, Pearlyne Willie Wong, April Tang Yee Ying, Ummi Kalthum Azlan, Hamizah Shahirah Hamezah, Ahmed Mediani et al. · 2025 · The Open Medicinal Chemistry Journal
  56. A review of evidence supporting amyloid beta reduction as a surrogate endpoint in Alzheimer’s disease
    Tianle Chen, R. Matthew Hutchison, Carrie E. Rubel, Jennifer Mary Murphy, Jing Xie, John T. O'Gorman, Gersham W. Dent, Geert Molenberghs, Maria Pia Sormani, Suzanne B. Hendrix et al. · 2026 · The Journal of Prevention of Alzheimer s Disease
  57. Decoding the secretase puzzle in amyloid-β generation: A state-of-the-art overview of the protease-mediated APP processing cascade in Alzheimer’s disease
    Zuzanna Senkowska, Ewelina Węglarz‐Tomczak · 2026 · Ageing Research Reviews
  58. Loss of Proteostasis and Early-Onset Neurodegeneration in Down Syndrome: From Mechanisms to Interventions
    Antonella Tramutola, Chiara Lanzillotta, Fabio Di Domenico, Eugenio Barone, Marzia Perluigi A · 2026 · Antioxidants
  59. Mitochondria‐Targeted Nanotherapies in Aging Neurodegenerative Disorders: Emerging Prospects and Clinical Potential
    Dnyandev G. Gadhave, Ashish B. Jadhav, Nitin Waghamode, Shubham V. Khot, Rajiya Khan, Ravi D. Hole, Shankar M. Dhobale, Manoj K. Aswar, Keshav Raj Paudel · 2026 · Advanced Healthcare Materials
  60. Using Genome Editing for Alzheimer’s Disease Therapy: from Experiment to Clinic
    M. Yu. Stepanichev · 2021 · Neurochemical Journal
  61. Generation of induced pluripotent stem cell line (XWHNi002-A) from a female with APP gene mutation
    Wenxian Sun, Pin Wang, Jin Gong, Yufei Chen, Yuting Yang, Heya Luan, Shaoqi Li, Ruina Li, Cuibai Wei · 2023 · Stem Cell Research
  62. Different clinical and neuroimaging features of Japanese dementia siblings with a new N-terminal mutation (Val225Ala) of APP gene
    Yasuyuki Ohta, Nozomi Hishikawa, Ken Ikegami, Kota Sato, Yosuke Osakada, Mami Takemoto, Toru Yamashita, Yoshio Omote, Takeshi Ikeuchi, Koji Abe · 2020 · Journal of Clinical Neuroscience
  63. Role of caspases, apoptosis and additional factors in pathology of Alzheimer's disease
    Anil Gupta · 2021 · Elsevier eBooks
  64. A Scalable High Throughput Fully Automated Pipeline for the Quantification of Amyloid Pathology in Alzheimer’s Disease using Deep Learning Algorithms
    Vivek Gopal Ramaswamy, Monika Ahirwar, Gennadi Ryan, Maxim Signaevsky, Vahram H. Haroutunian, Steven M. Finkbeiner · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  65. Exploring the Potential of Herbal Compounds as Autophagy Modulators in Alzheimer's Disease: A Comprehensive Review
    Ekta Yadav, Ashok Kumar Mandal, Ajay Kumar Sah, Sandesh Poudel, Prateek Pathak, Habibullah Khalilullah, Mariusz Jaremko, Abdul-Hamid M. Emwas, Pankajkumar S. Yadav, Amita Verma · 2024 · CNS & Neurological Disorders - Drug Targets
  66. Mendelian randomization and genetic pleiotropy analysis for the connection between inflammatory bowel disease and Alzheimer's disease
    Yuxuan Wu, Yu Yan, Jike Qi, Yuxin Liu, Ting Wang, Hao Chen, Xinying Guan, Zheng Chu, Ping Zeng · 2024 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  67. Morphological changes in cerebrospinal fluid production
    Hubert Paszkowycz, Łukasz Hubert Olewnik, Bartosz Gonera, Robert Haładaj, Nicol Zielińska · 2024 · Folia Morphologica
  68. Valosin-containing protein is cargo in Amyloid Precursor Protein extracellular vesicles
    Yue Lu, Mohammad Abdullah, Liam B. Healy, Tao Yin, Metin Yesiltepe, Luciano D’Adamio, Marc D. Tambini · 2026 · Cell Communication and Signaling
  69. Using Zebrafish to Study the Mechanisms That Underlie Down Syndrome
    Anna J. Moyer, Summer B. Thyme · 2025 · Springer eBooks
  70. Regional analysis of APOE polymorphism in Alzheimer’s disease in Spain
    Ignacio Pardo-Pérez, Leticia Sánchez-Valdeón, Ana García Gallego, Brisamar Estébanez, Inés Casado Verdejo, Jesús Antonio Fernández-Fernández, Carlos Méndez-Martínez, Laura Bello-Corral · 2025 · Scientific Reports
  71. Natural Products and Exercise Synergy: Unraveling Molecular Mechanisms to Enhance Brain Function in Alzheimer's Disease
    Long Chen, Xin Wang, Qi Zheng, Hang Wang · 2025 · Phytotherapy Research
  72. Genetic variation in the Nr1d1 transcription factor binding site shapes metabolism‐related protein networks associated with cognitive resilience in an Alzheimer's disease mouse reference panel
    Yu Zheng Chen, Tamara K. Stevenson, Yiding Cao, Lauren A. Fish, Julia E. Robbins, Gennifer E. Merrihew, Jea Park, Timothy J. Hohman, Michael J. MacCoss, Catherine Cook Kaczorowski · 2025 · Alzheimer s & Dementia
  73. Innovative Approaches to Alzheimer's Treatment: Utilizing Tacrine Hybrids to Inhibit Amyloid Beta Aggregation as a Strategic Focus
    Angamuthu Prabakaran, Amuthulakshmi Sivaperuman, Ramalakshmi Natarajan, Nalini Calambur Nagarajan, Viswas Raja Solomon · 2026 · Mini-Reviews in Medicinal Chemistry
  74. The Icelandic Mutation in the Murine APP Gene, mAPPA673T, on Amyloid-β Plaque Burden in the 5×FAD Alzheimer Model
    Anne Anschuetz, Renny Listyono, Thomas Vorley, Bettina Platt, Charles R. Harrington, Gernot Riedel, Karima Schwab · 2026 · Journal of Integrative Neuroscience
  75. Impact of Golgi dynamics and Golgi morphology on the regulation of glycosylation
    Paul A. Gleeson · 2026 · Biochimica et Biophysica Acta (BBA) - General Subjects
  76. The Dynamic Role of the Golgi Apparatus in Neuronal Function and Alzheimer’s Disease
    Lou Fourrière, Paul A. Gleeson · 2026 · Sub-cellular biochemistry/Subcellular biochemistry
  77. APP E590D mutation increases generation of Aβ and Aη peptides and exacerbates tauopathy
    Tian Liu, Liam Wetzel, David Roy, Kexin Zhang, Zexi Zhu, Pavan Kumaraguru, Viraj Gorthi, Hanna Jeon, Jung A. Woo, David E. Kang · 2026 · npj Dementia
  78. Pathogenic Protein Post-Translational Modifications in Alzheimer’s Disease: Mechanisms and Therapeutic Strategies
    A. Vijayalakshmi, Prabhakar Vengadasamy · 2026 · CNS & Neurological Disorders - Drug Targets
  79. Peptide-based therapeutics in the management of Alzheimer’s disease (AD) and their potential to develop novel strategies
    S. U. Nabi, Iyman Rasool, Andleeb Khan, Abrar Ul Haq, Iqra Hussain, Mosin Saleem Khan, Sabhiya Majid, Summya Rashid, Shahzada Mudasir Rashid, Nouroz Sehar et al. · 2026 · Metabolic Brain Disease
  80. Turning defense into damage: HIV-driven amyloidogenesis and neurotoxicity
    Feng Gu, Badeia Saed, Mojgan H. Naghavi · 2026 · mBio
  81. Multi-target therapeutic mechanisms of Azadirachta indica (Neem) in Alzheimer’s disease: Insights from network pharmacology and molecular docking approaches
    Md. Mainuddin Hossain, Juthi Adhikari, Abu Zaffar Shibly · 2026 · Pharmacological Research - Natural Products
  82. Toward common treatment strategies: convergent proteinopathies and mitochondrial dysfunction in Alzheimer’s and Parkinson’s diseases
    Julie E. V. Offerdahl, Danielle E. Mor · 2026 · Frontiers in Neuroscience
  83. Post-transcriptional regulation
    Ayeman Amanullah · 2022 · Elsevier eBooks
  84. Omega-3 fatty acids and neurodegenerative diseases: Focus on Alzheimer's disease
    Nasar Ullah Khan Niazi, Song Cai · 2023 · Elsevier eBooks
  85. Chebyshev Inequality and the Identification of Genes Associated with Alzheimer’s Disease
    Lei Yu, Xueli Tan, Delin Luo, Lin Yang, Xinping Pang, Zheng-chao Shan, Chengjiang Zhu, Jeng‐Shyang Pan, Chao-Yang Pang · 2024 · Lecture notes in electrical engineering
  86. Serotonin receptors - a potential target for the treatment of Alzheimer’s disease
    Dmitry V. Eremin, Elena M. Kondaurova, Alexander Ya. Rodnyy, K. A Molobekova, Dmitry Anatolievich Kudlay, Vladimir S. Naumenko · 2023 · Biochemistry (Moscow)
  87. Neuron-Astrocyte Interactions in Aging and Alzheimer's Disease: Dysregulation of Amyloid Precursor Protein
    Gretsen Velezmoro Jáuregui, Vladimir Parpura · 2025 · Ageing & Longevity
  88. The Biological Basis of Aging
    Junko Oshima, Fuki Marie Hisama, George M. Martin · 2019 · Elsevier eBooks
  89. Clinical and biological significance of RNA N6-methyladenosine regulators in Alzheimer disease
    Zhiqiang Qiu, Xuanyang Bai, Xinye Han, Peishen Wang, Xiang Wang, Yuxia Lv, Yihua An · 2023 · Medicine
  90. Loss of CDC50A function drives Aβ/p3 production via increased β/α-secretase processing of APP
    Marc D. Tambini, Luciano D'adamio · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  91. DeepGWAS: Enhance GWAS Signals for Neuropsychiatric Disorders via Deep Neural Network
    Jia Wen, Gang Li, Jiawen Carmen Chen, Quan Sun, Weifang Liu, Wyliena Guan, Ben Lai, Haibo Zhou, Jin Szatkiewicz, Xin He et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  92. Alzheimer's Disease Investigated via Gene-Environment Interactions, Biochemical Pathways, Cellular Processes, and Disease Phenotype Variability
    Viqas Shafi, Ifrah Siddiqui · 2024 · Research Square
  93. Mitochondrial Dynamics and Bioenergetics in iPSC-Derived Neurons with Familial Alzheimer’s Disease Mutations
    Courtney MacMullen, Neelam Sharma, Ronald L. Davis · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  94. Bridging Health Disparity Gaps in Alzheimer’s Disease among Marginalized Populations: Clinical Proteomics as a Case Study
    Henry A. Adeola, Renã A. S. Robinson · 2025 · ACS Bio & Med Chem Au
  95. Deciphering the Molecular and Genetic Basis of Alzheimer’s Disease
    Shamprasd Varija Raghu, Avinash Kundadka Kudva · 2022 · Springer eBooks
  96. Different Therapeutic Approaches to Alzheimer's Disease
    Thomas Magee, Yana Zubarev · 2023 · Journal of Student Research
  97. New Therapeutic Approaches for Sensory Symptoms in Alzheimer’s Disease
    Chaitanya Reddy, Marta Madureira · 2022 · Journal of Student Research
  98. Curcumin Shows Neuroprotection against Oxidative Damage and Alters APP Processing Involving GSK-3β-mediated Protein O-GlcNAcylation
    Zhun Wang, Pei-Fei Tao, Yu-Ying Sun, Xijun Song, Han‐Chang Huang · 2023 · Research Square
  99. In vitro and in silico evaluation of the anti-amyloid and anti-inflammatory properties of curcumin and a V (IV) – curcumin complex in LPS-stimulated primary rat neurons-microglia mixed cultures
    Georgios Katsipis, Sophia N. Lavrentiadou, George D. Geromichalos, Maria P. Tsantarliotou, Eleftherios G. Halevas, G. Litsardakis, Αnastasia A. Pantazaki · 2023 · Research Square
  100. Role of Antioxidants, and Lifestyle in Managing Brain Disorders Oxidative Stress Biomarkers and Antioxidant Treatments in Brain Diseases
    Öznur Özge Özcan, Mesut Karahan, Muhsin Konuk · 2023 · Food bioactive ingredients